Evidence map›Paper›PMID 25124494›Full record

SynthesisCirculation2014

Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.

Moritz F Sinner, Nathan R Tucker, Kathryn L Lunetta, Kouichi Ozaki, J Gustav Smith, Stella Trompet, Joshua C Bis, Honghuang Lin, Mina K Chung, Jonas B Nielsen and 47 more

Abstract readComparative StudyMeta-Analysis
In one paragraph

Synthesis in Circulation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed, 14 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 14 syntheses or guidelines pooled it, 207 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association BetweenFrontiers in cardiovascular medicine · 2020
    Pooled it
  4. Pooled it
  5. Pooled it
  6. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2018
    Guideline
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2017
    Guideline
  11. Guideline
  12. Pooled it
  13. Pooled it
  14. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.Heart rhythm · 2012
    Guideline
  15. Trial
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

57 authors at 10 institutions in 5 countries.

Moritz F Sinner
Nathan R Tucker
Kathryn L Lunetta
Kouichi Ozaki
J Gustav Smith
Stella Trompet
Joshua C Bis
Honghuang Lin
Mina K Chung
Jonas B Nielsen
Steven A Lubitz
Bouwe P Krijthe
Jared W Magnani
Jiangchuan Ye
Michael H Gollob
Tatsuhiko Tsunoda
Martina Müller-Nurasyid
Peter Lichtner
Annette Peters
Elena Dolmatova
Michiaki Kubo
Jonathan D Smith
Bruce M Psaty
Nicholas L Smith
J Wouter Jukema
Daniel I Chasman
Christine M Albert
Yusuke Ebana
Tetsushi Furukawa
Peter W Macfarlane
Tamara B Harris
Dawood Darbar
Marcus Dörr
Anders G Holst
Jesper H Svendsen
Albert Hofman
Andre G Uitterlinden
Vilmundur Gudnason
Mitsuaki Isobe
Rainer Malik
Martin Dichgans
Jonathan Rosand
David R Van Wagoner
METASTROKE Consortium
AFGen Consortium
Emelia J Benjamin
David J Milan
Olle Melander
Susan R Heckbert
Ian Ford
Yongmei Liu
John Barnard
Morten S Olesen
Bruno H C Stricker
Toshihiro Tanaka
Stefan Kääb
Patrick T Ellinor
Christ University · INFord Motor Company (United States) · USMarcus (United States) · USMichael & Associates · USMylan (Switzerland) · CHNielsen (United States) · USPerformance Communications · USSmith Family · AUStella Therapeutics (United States) · USSusan G. Komen Breast Cancer Foundation · US

Funding

Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024989 · NCRR · CASE WESTERN RESERVE UNIVERSITY · PI DAVIS, PAMELA B · 2007 to 2011
$53.7M
Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
Women's Health Study: Continued Follow-upR01CA047988 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI BURING, JULIE E., LEE, I-MIN · 1991 to 2014
$28.2M
PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
Pharmacogenomics and Risk of Cardiovascular DiseaseU01HL069757 · NHLBI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI KRAUSS, RONALD M · 2001 to 2009
$24.7M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
Genome-Wide Association Analysis in Essential Hypertension (FEHGAS study)R01HL086694 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ARAVINDA CHAKRAVARTI · 2007 to 2026
$21.2M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
CIHRIntramural NIH HHSNCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124NCI NIH HHS CA 047988NCI NIH HHS R01 CA047988NCRR NIH HHS 1UL-RR024989NCRR NIH HHS UL1 RR024989NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1RR025005NHGRI NIH HHS U01 HG004402NHGRI NIH HHS U01HG004402NHLBI NIH HHS 1R01HL076784NHLBI NIH HHS 1R01 HL092577NHLBI NIH HHS HL 043851NHLBI NIH HHS HL065962NHLBI NIH HHS HL080295NHLBI NIH HHS HL087652NHLBI NIH HHS HL-093613NHLBI NIH HHS HL105756NHLBI NIH HHS HL69757NHLBI NIH HHS K23 HL114724NHLBI NIH HHS K23HL114724NHLBI NIH HHS K24 HL105780NHLBI NIH HHS K24HL105780NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01 HC055015NHLBI NIH HHS N01 HC055016NHLBI NIH HHS N01 HC055018NHLBI NIH HHS N01 HC055019NHLBI NIH HHS N01 HC055020NHLBI NIH HHS N01 HC055021NHLBI NIH HHS N01 HC055022NHLBI NIH HHS N01 HC055222NHLBI NIH HHS N01 HC085079NHLBI NIH HHS N01 HC085080NHLBI NIH HHS N01 HC085081NHLBI NIH HHS N01 HC085082NHLBI NIH HHS N01 HC085083NHLBI NIH HHS N01 HC085086NHLBI NIH HHS N01-HC-25195NHLBI NIH HHS N01-HC-55015NHLBI NIH HHS N01-HC-55016NHLBI NIH HHS N01-HC-55018NHLBI NIH HHS N01- HC-55019NHLBI NIH HHS N01-HC-55020NHLBI NIH HHS N01-HC-55021NHLBI NIH HHS N01-HC-55022NHLBI NIH HHS N02-HL-6-4278NHLBI NIH HHS R01 HL043851NHLBI NIH HHS R01 HL059367NHLBI NIH HHS R01 HL 068986NHLBI NIH HHS R01 HL068986NHLBI NIH HHS R01 HL073410NHLBI NIH HHS R01 HL076784NHLBI NIH HHS R01 HL080295NHLBI NIH HHS R01 HL085251NHLBI NIH HHS R01 HL086694NHLBI NIH HHS R01HL086694NHLBI NIH HHS R01 HL087641NHLBI NIH HHS R01HL087641NHLBI NIH HHS R01 HL087652NHLBI NIH HHS R01 HL090620NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01HL092577NHLBI NIH HHS R01 HL104156NHLBI NIH HHS R01HL104156NHLBI NIH HHS R01 HL105756NHLBI NIH HHS R01 HL111314NHLBI NIH HHS R01HL59367NHLBI NIH HHS R21 HL093613NHLBI NIH HHS RC1 HL099452NHLBI NIH HHS RC1-HL-099452NHLBI NIH HHS T32 HL007208NHLBI NIH HHS T32HL007208NHLBI NIH HHS U01 HL069757NHLBI NIH HHS U01 HL080295NHLBI NIH HHS U10 HL054512NHLBI NIH HHS U10HL054512NHLBI NIH HHS U19 HL069757NIA NIH HHS 1R01 AG028321NIA NIH HHS 1R01AG032098-01A1NIA NIH HHS AG023629NIA NIH HHS N01 AG012100NIA NIH HHS N01 AG062101NIA NIH HHS N01 AG062103NIA NIH HHS N01 AG062106NIA NIH HHS R01 AG023629NIA NIH HHS R01 AG028321NIA NIH HHS R01 AG032098NIA NIH HHS R56 AG023629NIDDK NIH HHS DK063491NIDDK NIH HHS P30 DK063491NINDS NIH HHS R01 NS017950NINDS NIH HHS U01 NS069208NINDS NIH HHS U01-NS069208
6 · The paper itself

Abstract

backgroundAtrial fibrillation (AF) affects >30 million individuals worldwide and is associated with an increased risk of stroke, heart failure, and death. AF is highly heritable, yet the genetic basis for the arrhythmia remains incompletely understood. METHODS AND

resultsTo identify new AF-related genes, we used a multifaceted approach, combining large-scale genotyping in 2 ethnically distinct populations, cis-eQTL (expression quantitative trait loci) mapping, and functional validation. Four novel loci were identified in individuals of European descent near the genes NEURL (rs12415501; relative risk [RR]=1.18; 95% confidence interval [CI], 1.13-1.23; P=6.5×10(-16)), GJA1 (rs13216675; RR=1.10; 95% CI, 1.06-1.14; P=2.2×10(-8)), TBX5 (rs10507248; RR=1.12; 95% CI, 1.08-1.16; P=5.7×10(-11)), and CAND2 (rs4642101; RR=1.10; 95% CI, 1.06-1.14; P=9.8×10(-9)). In Japanese, novel loci were identified near NEURL (rs6584555; RR=1.32; 95% CI, 1.26-1.39; P=2.0×10(-25)) and CUX2 (rs6490029; RR=1.12; 95% CI, 1.08-1.16; P=3.9×10(-9)). The top single-nucleotide polymorphisms or their proxies were identified as cis-eQTLs for the genes CAND2 (P=2.6×10(-19)), GJA1 (P=2.66×10(-6)), and TBX5 (P=1.36×10(-5)). Knockdown of the zebrafish orthologs of NEURL and CAND2 resulted in prolongation of the atrial action potential duration (17% and 45%, respectively).

conclusionsWe have identified 5 novel loci for AF. Our results expand the diversity of genetic pathways implicated in AF and provide novel molecular targets for future biological and pharmacological investigation.

Indexed as

AgedAnimalsAtrial FibrillationChromosome MappingConnexin 43EuropeFemaleGene Knockdown TechniquesGenetic LociGenetic Predisposition to DiseaseGenotypeHomeobox Protein PITX2Homeodomain ProteinsHumansJapanMaleCAND2 protein, humanCand2 protein, zebrafishConnexin 43CUX1 protein, humanGJA1 protein, humanHomeobox Protein PITX2Homeodomain ProteinsMuscle Proteinsneurl1aa protein, zebrafishNEURL1 protein, humanNuclear ProteinsRepressor ProteinsT-Box Domain ProteinsT-box transcription factor 5Transcription FactorsUbiquitin-Protein LigasesZebrafish Proteinsatrial fibrillationepidemiologygene expressiongeneticspolymorphismsingle nucleotidezebrafish

Identifiers

PMID25124494
PMCPMC4190011
OpenAlexW2112387318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.